C12N 2770/18023
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2770/18023 (Virus like particles [vlp]) appears on 13 US grants and 29 published applications in this corpus.
Search patents in C12N- Granted patents
- 13
- Published applications
- 29
- Assignees
- 13
- Inventors
- 61
- Latest grant
- 11 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 1 | 1 |
| 2019 | 1 | 2 |
| 2020 | 1 | 2 |
| 2021 | 0 | 4 |
| 2022 | 4 | 2 |
| 2023 | 1 | 2 |
| 2024 | 3 | 5 |
| 2025 | 1 | 6 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Cancer immunotherapy using virus particles and immune checkpoint therapy11 Nov 2025US 12,465,624 B2Case Western Reserve University
- Melt processed viral nanoparticle constructs3 Dec 2024US 12,156,947 B2Case Western Reserve University
- Anti-cancer plant virus particles linked to HER2 antigens4 Jun 2024US 11,998,594 B2Case Western Reserve University
- Freeze dried viral nanoparticle constructs2 Apr 2024US 11,946,075 B2Case Western Reserve University
- Melt processed viral nanoparticle constructs23 May 2023US 11,654,117 B2Case Western Reserve University
- Cancer immunotherapy using virus particles and immune checkpoint therapy25 Jun 2026US 2026/0174813 A1Case Western Reserve University
- S100a9 vaccines for cancer and atherosclerosis30 Oct 2025US 2025/0332234 A1The Regents of the University of California
- Hydrogel formulations for vlp therapeutics3 Jul 2025US 2025/0213717 A1The Regents of the University of California
- Melt processed viral nanoparticle constructs19 Jun 2025US 2025/0195449 A1Case Western Reserve University
- Cancer immunotherapy using virus particles13 Feb 2025US 2025/0049866 A1
Most cited
By later US patents